帕金森病中血清GDF15水平与非运动症状之间的关系

相关实验视频

Updated: May 21, 2025

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

7.7K

Jianli Wang^1,2, Ting Geng³, Xiaomei Yao²

¹Department of Neurology, Qilu Hospital of Shandong University, Jinan, China.

Neurological research

|March 18, 2025

概括

较高的血清生长差异化因子15 (GDF15) 水平与帕金森病 (PD) 患者抑郁症和性功能障碍风险降低有关. 在PD中,GDF15可以作为这些非运动症状的生物标志物.

科学领域:

神经学神经学
生物标志物生物标志物
临床研究临床研究

背景情况:

帕金森病 (PD) 是一种神经退行性疾病,其特点是运动和非运动症状 (NMS).
非运动性症状显著影响PD患者的生活质量.
增长分化因子15 (GDF15) 是一种细胞因子,涉及各种生物过程,在神经疾病中扮演着新兴的角色.

研究的目的:

为了研究血清GDF15水平与帕金森病中的NMS之间的关联.
探索GDF15作为PD患者特定NMS的诊断生物标志物的潜力.

主要方法:

分析了102名帕金森病患者的队列.
测量了血清GDF15水平,并与人口和临床数据相关联.
使用线性回归和接收器操作特征 (ROC) 曲线分析来评估相关性和诊断价值.

主要成果:

血清GDF15水平在男性和女性PD患者之间没有显著差异.
GDF15水平与PD发病年龄,农药暴露,抑郁症,性功能障碍,爱普沃思睡眠度量表 (ESS) 和汉密尔顿抑郁度量表 (HAMD) 相关.
增加的GDF15与抑郁症和性功能障碍有负相关性,与ESS有正相关性. 每增加10 pg/ml的GDF15与抑郁症风险降低4%和性功能障碍风险降低5%有关.

结论:

血清GDF15水平升高与帕金森病中抑郁症和性功能障碍的风险降低有关.
血清GDF15显示为区分PD患者抑郁症和性功能障碍的生物标志物的潜力.

关键词:

帕金森病是帕金森氏症的一种疾病.抑郁抑郁症抑郁症抑郁症抑郁症增长差异化因子-15-15 其他非运动症状.血液中的血清是血清.

相关概念视频

01:24

Parkinson's Disease: Treatment

170

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

170

01:15

Parkinson's Disease: Overview

405

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

405

01:37

Neural Regulation

39.0K

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.